These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20035502)

  • 21. Prophylaxis and acute therapy of arterial embolism with special reference to cerebral embolism.
    Tettenborn B; Krämer G; Erbel R
    Herz; 1991 Dec; 16(6):444-55. PubMed ID: 1765348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis.
    Qureshi AI; Kirmani JF; Hussein HM; Harris-Lane P; Divani AA; Suri MF; Janjua N; Alkawi A
    Neurosurgery; 2006 Nov; 59(5):1044-51; discussion 1051. PubMed ID: 17143239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
    Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
    Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
    Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
    J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evidence for medicine versus surgery for carotid stenosis.
    Ederle J; Brown MM
    Eur J Radiol; 2006 Oct; 60(1):3-7. PubMed ID: 16920313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term outcome after endovascular treatment of high-risk patients with recurrently symptomatic intracranial stenoses of the posterior circulation].
    Wittkugel O; Rosenkranz M; Burckhardt D; Niessen WD; Espersen T; Zeumer H; Fiehler J; Grzyska U
    Rofo; 2009 Aug; 181(8):782-91. PubMed ID: 19401972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management trumps stenting for intracranial arterial stenosis.
    Rosenberg K
    Am J Nurs; 2011 Dec; 111(12):16. PubMed ID: 22112875
    [No Abstract]   [Full Text] [Related]  

  • 30. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.
    Derdeyn CP; Chimowitz MI
    Neuroimaging Clin N Am; 2007 Aug; 17(3):355-63, viii-ix. PubMed ID: 17826637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research priorities for intracranial atherosclerotic diseases.
    Qureshi AI; Taylor RA
    J Neuroimaging; 2009 Oct; 19 Suppl 1():39S-42S. PubMed ID: 19807858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current management of symptomatic intracranial stenosis: medical versus endovascular therapy.
    Weigele JB; Taylor RA; Kasner SE
    Curr Atheroscler Rep; 2007 Oct; 9(4):296-304. PubMed ID: 18173957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow failure from intracranial atherosclerotic disease: a rationale for endovascular intervention in a population with recurrent symptoms despite maximal medical therapy.
    Fargen KM; Velat GJ; Lawson MF; Khanna AY; Hoh B; Mocco J
    J Neurointerv Surg; 2013 Jul; 5(4):e17. PubMed ID: 22661599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial atherosclerosis.
    Qureshi AI; Caplan LR
    Lancet; 2014 Mar; 383(9921):984-98. PubMed ID: 24007975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endovascular treatment of intracranial atherosclerotic disease.
    Lenart CJ; Binning MJ; Veznedaroglu E
    Neuroimaging Clin N Am; 2013 Nov; 23(4):653-9. PubMed ID: 24156856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management strategies in posterior circulation intracranial atherosclerotic disease.
    Povedano G; Zuberbuhler P; Lylyk P; Ameriso SF
    J Endovasc Ther; 2010 Jun; 17(3):308-13. PubMed ID: 20557167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.
    Banerjee C; Chimowitz MI
    Circ Res; 2017 Feb; 120(3):502-513. PubMed ID: 28154100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution and role of endovascular therapy for the treatment of intracranial atherosclerotic disease.
    Rasmussen PA;
    J Neuroimaging; 2009 Oct; 19 Suppl 1():30S-4S. PubMed ID: 19807856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial atherosclerotic disease.
    Battistella V; Elkind M
    Eur J Neurol; 2014 Jul; 21(7):956-62. PubMed ID: 24612339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Symptomatic Intracranial Stenosis.
    Hoak DA; Lutsep HL
    Curr Cardiol Rep; 2016 Sep; 18(9):83. PubMed ID: 27443379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.